Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

The Electron Transport Chain

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Cellular Injury IV: Necrosis

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molnupiravir; molecular and functional descriptors of mitochondrial safety.

Toxicology and applied pharmacology·2022

Same author

Remdesivir; molecular and functional measures of mitochondrial safety.

Toxicology and applied pharmacology·2021

Same author

Structure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.

Toxicology letters·2013

Same author

Changes in myofilament proteins, but not Ca²⁺ regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure.

American journal of physiology. Heart and circulatory physiology·2011

Same author

Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.

Toxicology·2011

Same author

Urea cycle gene expression is suppressed by PFOA treatment in rats.

Toxicology letters·2010

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Adriamycin-induced oxidative mitochondrial cardiotoxicity.

J M Berthiaume¹, K B Wallace

¹Toxicology Graduate Program, Medical School, University of Minnesota, Duluth, Minnesota 55812, USA.

Cell Biology and Toxicology

|September 30, 2006

Summary

Adriamycin (ADR) causes heart damage through reactive oxygen species (ROS) generated by its redox cycling. Mitochondria are key targets, contributing significantly to ADR cardiotoxicity.

Area of Science:

Cardiology
Pharmacology
Biochemistry

Background:

Adriamycin (ADR) is an effective anticancer drug but causes dose-limiting cardiotoxicity.
The precise mechanisms of ADR-induced cardiotoxicity are debated, but reactive oxygen species (ROS) are implicated.
Mitochondria are considered a primary target for ADR's oxidative stress effects.

Purpose of the Study:

To review the effects of ADR redox cycling on mitochondria.
To support the hypothesis that mitochondria play a major role in ADR cardiotoxicity.
To advance understanding of ADR toxicity mechanisms using clinically relevant cardiac models.

Main Methods:

Review of existing literature on Adriamycin (ADR) cardiotoxicity.
Focus on studies investigating ADR's effects on mitochondrial function.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Related Experiment Videos

Last Updated: Jul 19, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Emphasis on studies using cardiac models with clinically relevant ADR doses.

Main Results:

ADR redox cycling induces reactive oxygen species (ROS) in the heart.
Mitochondria are significantly affected by ADR-induced oxidative stress.
Evidence supports mitochondria as a major contributor to ADR cardiotoxicity.

Conclusions:

Mitochondrial dysfunction is a key mechanism in Adriamycin (ADR) cardiotoxicity.
Understanding these mechanisms can guide the development of strategies to mitigate ADR's cardiotoxic effects.
Further research using relevant models is crucial for therapeutic advancements.